Aptivus Interactions
There are 390 drugs known to interact with Aptivus (tipranavir), along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 113 are major, 274 are moderate, and 3 are minor.
- View all 390 medications that may interact with Aptivus
- View Aptivus alcohol/food interactions (2)
- View Aptivus disease interactions (4)
Most frequently checked interactions
View interaction reports for Aptivus (tipranavir) and the medicines listed below.
- Actemra (tocilizumab)
- Aggrenox (aspirin / dipyridamole)
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- CellCept (mycophenolate mofetil)
- Cerdelga (eliglustat)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Crixivan (indinavir)
- Cymbalta (duloxetine)
- Depakote Sprinkles (divalproex sodium)
- Dilaudid (hydromorphone)
- Entyvio (vedolizumab)
- Fuzeon (enfuvirtide)
- Hemlibra (emicizumab)
- Imbruvica (ibrutinib)
- Intelence (etravirine)
- Isentress (raltegravir)
- Januvia (sitagliptin)
- Kalydeco (ivacaftor)
- Lyrica (pregabalin)
- Norvir (ritonavir)
- Ofev (nintedanib)
- Procysbi (cysteamine)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Stivarga (regorafenib)
- Trizivir (abacavir / lamivudine / zidovudine)
Aptivus alcohol/food interactions
There are 2 alcohol/food interactions with Aptivus (tipranavir).
Aptivus disease interactions
There are 4 disease interactions with Aptivus (tipranavir) which include:
Report options
QR code containing a link to this page
More about Aptivus (tipranavir)
- Aptivus consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: protease inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
